Abstract:I read with great interest the article on “Neuropathic Pain in Acute and Subacute Neuropathies:A Systematic Review” by Artemiadis and Zis (1). I wanted to commend the authors for their careful study and hard work, as the results would be very useful for both clinical and research purposes. Also, the overview of the various etiologies of acute/subacute peripheral neuropathies (APN) was informative, and can be used in clinical treatment. I do have some comments about this article. First of all, I took an interest in the literature search and the study selection. After careful section, the review included 70 articles published between 1995 and 2017. However, it is a limited selection in that all of the studies were searched by Medline and very few studies were targeted primarily on neuropathic pain (NP). As a result, some studies may have been missed. Moreover, Guillain-Barre syndrome (GBS) accounted for the majority of patients with APN, which had a great influence on the pooled incidence of NP. In my opinion, the incidence of NP in various causes of APN is more valuable than the pooled incidence of NP in APN. Fortunately, the incidence of NP in various causes of APN was also described in the results and summarized in Table 1, which brought us a clearer picture of the figures. Another limitation was the diagnosis of NP. As it was mentioned in this article, adequate diagnosis of NP was lacking as not all studies reported how NP was defined or whether validated tools for the diagnosis of the neuropathic element of pain were used (1). The criteria of NP should be based on both clinical judgment and tools such as electrophysiologic examination, which could be another research objective. I am also curious about the causes of acute/subacute painful neuropathies. Some causes could be a great help of clinical treatment such as diabetes-related acute/subacute neuropathies. It was shown in the results section that the incidence of NP in treatmentinduced peripheral neuropathy of diabetes (TIND) was 100%, and the incidence of NP in diabetic cervical/ lumber radiculo-plexopathy was 86.4% (range: 81.2%100%), which means the diabetes-related acute/subacute neuropathies are almost always pain (1). Russell JW et al (2) suggest that Diabetic neuropathy is common and can present with varied clinical presentations. Although treatment currently focuses on pain management, attention should be paid to potential risk factors for neuropathy. For example, glycemic control, hyperlipidemia, and hypertension should be managed with diet, exercise, and medications. TIND (also known as “insulin neuritis”) is an acute painful neuropathy occurring within about 2 months after rapid correction of serum glucose or a decrease above 2% of glucosylated haemoglobin (HB1ac) per 3 months, with insulin or oral hypoglycemic agents after a long history of hyperglycemia (1). So the use of insulin or oral hypoglycemic agents needs to be carefully monitored. Doses should start small at first, and lower glucose levels gradually. Serum glucose monitoring should be improved to prevent painful neuropathies. I would like to consult with the authors about a question. Peripheral neuropathies are diseases of the peripheral nervous system that can be divided into mononeuropathies, multifocal neuropathies, and polyneuropathies (3). So, why were articles referring to mononeuropathies and monoradiculopathies excluded in the search strategy? I would very much appreciate a reply.

Clinical Practice Guidelines for the Management of Neuropathic Pain: a Systematic Review

Quality Assessment of Cancer Pain Clinical Practice Guidelines

Non-invasive Brain Stimulation Interventions for Management of Chronic Central Neuropathic Pain: a Scoping Review Protocol

Quality of Critical Care Clinical Practice Guidelines: Assessment with AGREE II Instrument.

Quality appraisal of clinical practice guidelines for motor neuron diseases or related disorders using the AGREE II instrument

Assessment of the methodological, recommendation and reporting quality of global guidelines for neck pain and synthesis of evidence and recommendations: a systematic review protocol

Critical Appraisal of International Guidelines for the Management of Diabetic Neuropathy: is There Global Agreement in the Internet Era?

Clinical Practice Guidelines for Hypertension in China: A Systematic Review of the Methodological Quality

Critical evaluation of the quality and recommendations of clinical practice guidelines for nasopharyngeal carcinoma

Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration

Assessing the Quality of Global Clinical Practice Guidelines on Gout Using AGREE II Instrument.

Managing Chronic Neuropathic Pain: Recent Advances and New Challenges

Are clinical practice guidelines for low back pain interventions of high quality and updated? A systematic review using the AGREE II instrument

Re: Neuropathic Pain In Acute And Subacute Neuropathies: A Systematic Review

Neuropathic pain: Evidence based recommendations

Neuropharmacology of Neuropathic Pain: A Systematic Review

Clinical practice guidelines of Chinese patent medicine in China: A critical review

[PP.26.09] QUALITY OF CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION, A SYSTEMATIC ANALYSIS USING THE AGREE II INSTRUMENT

The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update

Critical Appraisal of the Quality of Clinical Practice Guidelines for Idiopathic Pulmonary Fibrosis.

Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain